Susceptibility of uncommon Candida species to systemic antifungals by the EUCAST methodology

Med Mycol. 2020 Aug 1;58(6):848-851. doi: 10.1093/mmy/myz121.

Abstract

The incidence of infections by uncommon Candida species has increased in recent years, however, in vitro susceptibility data are scarce. Here we assess the susceptibility of C. krusei, C. dubliniensis, C. lusitaniae, and C. guilliermondii complex isolates (n = 120) to antifungal agents by the EUCAST methodology. C. dubliniensis proved to be the most susceptible species, similar to that of C. albicans (P < .05), whereas C. guilliermondii was the least susceptible. Two C. krusei isolates were echinocandin-resistant and harbored a point mutation (L701M) in the FKS1. Some isolates were either fluconazole-resistant (C. lusitaniae, n = 2) or fluconazole non-wild type (C. guilliermondii, n = 3).

Keywords: Candida dubliniensis; Candida guilliermondii; Candida krusei; Candida lusitaniae; EUCAST.

MeSH terms

  • Antifungal Agents / pharmacology*
  • Candida / classification*
  • Candida / drug effects*
  • Candida / genetics
  • Candidiasis / microbiology
  • Drug Resistance, Fungal / genetics*
  • Humans
  • Microbial Sensitivity Tests / methods
  • Point Mutation

Substances

  • Antifungal Agents